Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Wieczorek

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2009
Endothelial and red blood cell turnover rate--factors possibly affecting circulating ADMA levels?Andrzej Surdacki, Ewa Wieczorek-Surdacka
Clinical Chemistry and Laboratory Medicine|June 10, 2022
Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessmentEwa Wieczorek, Agnieszka Ćwiklińska, Maciej Jankowski
Circulation|October 28, 2015
Letter by Kruszelnicka et al regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"Olga Kruszelnicka, Ewa Wieczorek-Surdacka, Andrzej Surdacki
International Journal of Molecular Sciences|February 6, 2016
Effects of Atorvastatin Dose and Concomitant Use of Angiotensin-Converting Enzyme Inhibitors on Renal Function Changes over Time in Patients with Stable Coronary Artery Disease: A Prospective Observational StudyEwa Wieczorek-Surdacka, Jolanta Świerszcz, Andrzej Surdacki
Przeglad Lekarski|June 3, 2010
[Chronic kidney disease in the source documentation of the outpatient clinic Department of Nephrology. Part I. Causes of renal failure and characteristics of the studied population]Jerzy Kopeć, Rafał Januszek, Ewa Wieczorek-Surdacka, et al.
Folia Medica Cracoviensia|April 6, 2021
Novel antidiabetic drugs in diabetic kidney disease accompanying type 2 diabetes - a minireviewEwa Wieczorek-Surdacka, Andrzej Surdacki, Jolanta Świerszcz, et al.
Journal of Clinical Medicine|July 14, 2023
Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet TherapyBernadeta Chyrchel, Olga Kruszelnicka, Ewa Wieczorek-Surdacka, et al.
International Journal of Molecular Sciences|January 28, 2026
Very-Low-Density Lipoproteins Quantity but Not Composition Is Altered in Normotriglyceridemic Subjects with Elevated Lipoprotein (a) LevelEwa Wieczorek-Breitzke, Martyna Feliksiak, Agnieszka Kuchta, et al.
Przeglad Lekarski|June 3, 2010
[Chronic kidney disease in the source documentation of the outpatient clinic Department of Nephrology. Part II. Comparison of the three different methods of glomerular filtration rate estimation]Jerzy Kopeć, Rafał Januszek, Ewa Wieczorek-Surdacka, et al.
Przeglad Lekarski|July 15, 2011
[Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease]Ewa Wieczorek-Surdacka, Ireneusz Kaczmarczyk, Piotr Jasik, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2009
Endothelial and red blood cell turnover rate--factors possibly affecting circulating ADMA levels?Andrzej Surdacki, Ewa Wieczorek-Surdacka
Clinical Chemistry and Laboratory Medicine|June 10, 2022
Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessmentEwa Wieczorek, Agnieszka Ćwiklińska, Maciej Jankowski
Circulation|October 28, 2015
Letter by Kruszelnicka et al regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"Olga Kruszelnicka, Ewa Wieczorek-Surdacka, Andrzej Surdacki
International Journal of Molecular Sciences|February 6, 2016
Effects of Atorvastatin Dose and Concomitant Use of Angiotensin-Converting Enzyme Inhibitors on Renal Function Changes over Time in Patients with Stable Coronary Artery Disease: A Prospective Observational StudyEwa Wieczorek-Surdacka, Jolanta Świerszcz, Andrzej Surdacki
Przeglad Lekarski|June 3, 2010
[Chronic kidney disease in the source documentation of the outpatient clinic Department of Nephrology. Part I. Causes of renal failure and characteristics of the studied population]Jerzy Kopeć, Rafał Januszek, Ewa Wieczorek-Surdacka, et al.
Folia Medica Cracoviensia|April 6, 2021
Novel antidiabetic drugs in diabetic kidney disease accompanying type 2 diabetes - a minireviewEwa Wieczorek-Surdacka, Andrzej Surdacki, Jolanta Świerszcz, et al.
Journal of Clinical Medicine|July 14, 2023
Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet TherapyBernadeta Chyrchel, Olga Kruszelnicka, Ewa Wieczorek-Surdacka, et al.
International Journal of Molecular Sciences|January 28, 2026
Very-Low-Density Lipoproteins Quantity but Not Composition Is Altered in Normotriglyceridemic Subjects with Elevated Lipoprotein (a) LevelEwa Wieczorek-Breitzke, Martyna Feliksiak, Agnieszka Kuchta, et al.
Przeglad Lekarski|June 3, 2010
[Chronic kidney disease in the source documentation of the outpatient clinic Department of Nephrology. Part II. Comparison of the three different methods of glomerular filtration rate estimation]Jerzy Kopeć, Rafał Januszek, Ewa Wieczorek-Surdacka, et al.
Przeglad Lekarski|July 15, 2011
[Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease]Ewa Wieczorek-Surdacka, Ireneusz Kaczmarczyk, Piotr Jasik, et al.
Pageof 4